JillLacyMD

Oncology • New Haven, CT

Associate Professor of Medical Oncology, Yale University

Join to view full profile

Dr. Lacy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Lacy's full profile

Already have an account?

Office
20 York St
New Haven, CT 06510
Phone+1 203-200-4422

Fax+1 203-200-6950
Is this information wrong?

Education & Training

Yale-New Haven Medical CenterFellowship, Medical Oncology, 1983 - 1985
Yale-New Haven Medical CenterResidency, Internal Medicine, 1982 - 1983
Yale-New Haven Medical CenterResidency, Internal Medicine, 1978 - 1980
Yale School of MedicineClass of 1978

Certifications & Licensure

CT State Medical License 1981 - 2024
CO State Medical License 1992 - 1995
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Top Doctors: New York Metro Area Castle Connolly, 2006-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
America's Top Doctors for Cancer Castle Connolly, 2006-2013
New York Magazine: Top Doctors Castle Connolly, 2006, 2008
Join now to see all

Clinical Trials

FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer Start of enrollment: 2008 May 01
Completed
Phase 2
Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer Start of enrollment: 2011 Oct 01
Completed
Phase 2
The Effect of Sorafenib on Portal Pressure Start of enrollment: 2011 Aug 01
Completed
Phase 2
Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer Start of enrollment: 2014 Mar 25
Active, not recruiting
Phase 2
Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer Start of enrollment: 2014 Jul 01
Completed
Phase 1
Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery Start of enrollment: 2018 Feb 06
Active, not recruiting
Phase 1, Phase 2
A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies Start of enrollment: 2019 Nov 06
Active, not recruiting
Phase 1
Roles: Principal Investigator, Contact
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer Start of enrollment: 2022 Aug 08
Recruiting
Phase 2, Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
Michael Cecchini, James M Cleary, Yu Shyr, Joseph Chao, Nataliya Uboha, May Cho, Anthony Shields, Shubham Pant, Laura Goff, Kristen Spencer, Edward Kim, Stacey Stein, ...> ;British Journal of Cancer. 2024 Feb 1
Pre-operative chemoradiotherapy with or without induction chemotherapy for operable locally-advanced esophageal cancer.
Gabrielle W Peters, Wesley Talcott, Nicholas V Peters, Andrew Dhanasopan, Jill Lacy, Michael Cecchini, Jeremy Kortmansky, Stacey Stein, Stephen Lattanzi, Daniel Boffa,...> ;Journal of Gastrointestinal Oncology. 2023 Jun 30
5 citations
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
Ko, A., Kim, K., Siveke, J., Lopez, C., Lacy, J., O'Reilly, E., Macarulla, T., Manji, G., Lee, J., Ajani, J., Alsina Maqueda, M., Rha, S., Lau, J., Al-Sakaff, N., Alle...> ;The Oncologist. 2023 Jun 2
Quantitative DNA Repair Biomarkers and Immune Profiling for Temozolomide and Olaparib in Metastatic Colorectal Cancer.
Michael Cecchini, Janie Y Zhang, Wei Wei, Jeffrey Sklar, Jill Lacy, Minghao Zhong, Yong Kong, Hongyu Zhao, Jassim DiPalermo, Lesley Devine, Stacey M Stein, Jeremy Kort...> ;Cancer Research Communications. 2023 Jun 1
2 citations
Precision Medicine for Pancreas Cancer Treatment: A Multidisciplinary Challenge or Opportunity?
James J Farrell, Marie E Robert, Jill Lacy> ;Clinical Gastroenterology and Hepatology. 2023 Oct 1
32 citations
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, Thierry Alcindor, Angela N Bartley, Aubrey Belk Malowany, Nishin A Bhadkamkar, Dana C Deighton, Yelena Janjigian...> ;Journal of Clinical Oncology. 2023 Mar 1
4 citations
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarc...
Brandon M Huffman, Atrayee Basu Mallick, Nora K Horick, Andrea Wang-Gillam, Peter Joel Hosein, Michael A Morse, Muhammad Shaalan Beg, Janet E Murphy, Sharon Mavroukaki...> ;JAMA Network Open. 2023 Jan 3
An Appraisal of Immunohistochemical Stain Use in Hepatic Metastasis Highlights the Effectiveness of the Individualized, Case-Based Approach: Analysis of Data From a Te...
Jeff D Wang, Christopher Sebastian, Zenta Walther, Tejas Suresh, Jill Lacy, Xuchen Zhang, Dhanpat Jain> ;Archives of Pathology & Laboratory Medicine. 2023 Feb 1
Yale Precision Medicine Tumor Board: reawakening the guardian of the genome.
Michael J Grant, Karin E Finberg, Zenta Walther, Stacey M Stein, Jill Lacy, Joseph P Eder, Sarah B Goldberg> ;The Lancet. Oncology. 2022 Mar 1
485 citations
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Jaffer A Ajani, Thomas A D'Amico, David J Bentrem, Joseph Chao, David Cooke, Carlos Corvera, Prajnan Das, Peter C Enzinger, Thomas Enzler, Paul Fanta, Farhood Farjah, ...> ;Journal of the National Comprehensive Cancer Network. 2022 Feb 1
32 citations
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.
Mark Yarchoan, Leslie Cope, Amanda N Ruggieri, Robert A Anders, Anne M Noonan, Laura W Goff, Lipika Goyal, Jill Lacy, Daneng Li, Anuj K Patel, Aiwu R He, Ghassan K Abo...> ;The Journal of Clinical Investigation. 2021 Dec 15
Pre-Operative Chemoradiotherapy With or Without Induction Chemotherapy for Operable Locally-Advanced Esophageal Cancer.
Gabrielle W. Peters, Shaobin Wang, N V Peters, A Dhanasopan, Jill Lacy, Michael Cecchini, Jeremy S. Kortmansky, Stacey Stein, P L Kunz, S Lattanzi, Henry S. Park, Dani...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
4 citations
Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma
Yasheen Gao, Melinda Wang, Xiaojia Guo, Joanna Hu, Tian-min Chen, Sade´ M. B. Finn, Jill Lacy, John W. Kunstman, Charles Cha, Melena D. Bellin, Marie E. Robert, Gary V...> ;Plos One. 2021 Sep 29
5 citations
Margin negative resection and pathologic downstaging with multiagent chemotherapy with or without radiotherapy in patients with localized pancreas cancer: A national c...
Joseph A. Miccio, Wesley J. Talcott, Timil Patel, Henry S. Park, Michael Cecchini, Ronald R. Salem, Sajid A. Khan, Stacey Stein, Jeremy S. Kortmansky, Jill Lacy, Amol ...> ;Clinical and Translational Radiation Oncology. 2021 Mar 1
16 citations
Microsatellite Instability and KRAS Mutation in Stage IV Colorectal Cancer: Prevalence, Geographic Discrepancies, and Outcomes From the National Cancer Database
Johannes Uhlig, Michael Cecchini, Amar H. Sheth, Stacey Stein, Jill Lacy, Hyun Soo Kim> ;Journal of the National Comprehensive Cancer Network. 2021 Feb 2
4 citations
Evaluation of the Cost-effectiveness of Doublet Therapy in Metastatic BRAF Variant Colorectal Cancer.
Kishan Patel, Stacey Stein, Jill Lacy, Mark H. O'Hara, Scott F. Huntington> ;JAMA Network Open. 2021 Jan 4
Clinical outcomes of first line FOLFIRINOX vs . gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System
Timil Patel, Joseph A. Miccio, Michael Cecchini, Thejal Srikumar, Stacey Stein, Jeremy Kortmanksy, Kimberly L. Johung, Jill Lacy> ;Journal of Gastrointestinal Oncology. 2021 Jan 1
5 citations
A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
Michael Cecchini, Jeremy S. Kortmansky, Can Cui, Wei Wei, Jaykumar R. Thumar, Nataliya Volodymyrivna Uboha, Navid Hafez, Jill Lacy, Neal A. Fischbach, Kert D. Sabbath,...> ;Cancer. 2020 Dec 22
2 citations
A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline ...
Michael Cecchini, Joseph A. Miccio, Jay Pahade, Jill Lacy, Ronald R. Salem, Skyler B. Johnson, Adriana Blakaj, Stacey Stein, Jeremy S. Kortmansky, Kimberly L. Johung> ;Pancreas. 2020 Aug 1
117 citations
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Daniel V.T. Catenacci, Yoon-Koo Kang, Haeseong Park, Hope E. Uronis, Keun-Wook Lee, Matthew C.H. Ng, Peter C. Enzinger, Se Hoon Park, Philip J. Gold, Jill Lacy, Howard...> ;The Lancet. Oncology. 2020 Aug 1
191 citations
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen, Stefan Buettner, Mustafa Suker, Berend R. Beumer, Pietro Addeo, Philippe Bachellier, Nathan Bahary, Tanios Bekaii-Saab, Maria Antonietta Bali, Mar...> ;Journal of the National Cancer Institute. 2019 Aug 1
156 citations
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, rand...
Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, Sara Lonardi, Salah-Eddin Al-Batran, Eric Van Cutsem, David H. Ilson, Maria Alsina, Ian Chau, Jill Lacy, Michel D...> ;The Lancet. Oncology. 2019 Mar 1
177 citations
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma...
Ramesh K. Ramanathan, Shannon McDonough, Philip A. Philip, Sunil R. Hingorani, Jill Lacy, Jeremy S. Kortmansky, Jaykumar Ranchodbhai Thumar, E. Gabriela Chiorean, Anth...> ;Journal of Clinical Oncology. 2019 Feb 28
1 citations
Disappearing pigmentary mosaicism during imatinib treatment for gastrointestinal stromal tumors.
Emily Coleman, Gauri Panse, Shawn E. Cowper, Jill Lacy, Jonathan S. Leventhal> ;JAAD Case Reports. 2019 Jan 30
11 citations
Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database
Johannes Uhlig, Cortlandt M. Sellers, Charles Cha, Sajid A. Khan, Jill Lacy, Stacey Stein, Hyun Soo Kim> ;Annals of Surgical Oncology. 2019 Jan 28
Join now to see all

Press Mentions

2023 ‘Top Doctors’ List Features Over 250 Yale Medicine PhysiciansMay 3rd, 2023
Connecticut Magazine’s 2023 “Top Doctors” Issue Recognizes 82 Smilow Cancer Hospital and Yale Cancer Center PhysiciansMay 1st, 2023
Experts in TrainingJanuary 20th, 2021
Join now to see all

Grant Support

Medical Oncology, Hematology, And PharmacologyNational Cancer Institute2002
AIDS Lymphoma Using Antisense To EBV GenesNational Cancer Institute1995–2001
Studies Of AIDS Lymphoma Using Antisense To EBV GenesNational Cancer Institute1996–1997
EBV Transformation--Ebv Induced GenesNational Cancer Institute1994
EBV Transformation--Ebv-Induced GenesNational Cancer Institute1990–1993
EBV Transformation--Ebv-Induced GenesNational Cancer Institute1992
Molecular Events Of By Lymphocyte ImmortalizationNational Heart, Lung, And Blood Institute1985–1989